Abraham Ceesay insider trades

Open-market stock purchases and sales by Abraham Ceesay, Director at Charles River Laboratories International, Inc, from SEC Form 4 filings since Jan 17, 2018.

Recent trades

DateStockTradeValue
May 8, 2026CRL Charles River Laboratories International, IncBought (not open market)$255K
Feb 18, 2026RAPP Rapport Therapeutics, IncSold$103K
Feb 18, 2026RAPP Rapport Therapeutics, IncSold$68K
Feb 18, 2026RAPP Rapport Therapeutics, IncSold$86.6K
Feb 18, 2026RAPP Rapport Therapeutics, IncSold$62.6K
Feb 2, 2026RAPP Rapport Therapeutics, IncBought (not open market)—
Jan 20, 2026RAPP Rapport Therapeutics, IncSold$152K
Jan 20, 2026RAPP Rapport Therapeutics, IncSold$133K
Dec 17, 2025RAPP Rapport Therapeutics, IncSold$83.9K
Dec 17, 2025RAPP Rapport Therapeutics, IncSold$18.6K
Dec 17, 2025RAPP Rapport Therapeutics, IncSold$61.9K
Dec 17, 2025RAPP Rapport Therapeutics, IncSold$72.7K
Dec 17, 2025RAPP Rapport Therapeutics, IncSold$16K
Dec 17, 2025RAPP Rapport Therapeutics, IncSold$70.4K
Nov 17, 2025RAPP Rapport Therapeutics, IncSold$72.3K
Nov 17, 2025RAPP Rapport Therapeutics, IncSold$69.2K
Nov 17, 2025RAPP Rapport Therapeutics, IncSold$77.7K
Nov 17, 2025RAPP Rapport Therapeutics, IncSold$55.8K
Oct 15, 2025RAPP Rapport Therapeutics, IncSold$120K
Oct 15, 2025RAPP Rapport Therapeutics, IncSold$31K
Oct 15, 2025RAPP Rapport Therapeutics, IncSold$111K
Oct 15, 2025RAPP Rapport Therapeutics, IncSold$19.8K

Companies traded

  • CRL Charles River Laboratories International, Inc: other filings, last May 8, 2026
  • RAPP Rapport Therapeutics, Inc: 24 sales, last Feb 18, 2026
  • PCRX Pacira BioSciences, Inc: 1 sale, last Sep 4, 2025
  • CERE Cerevel Therapeutics Holdings, Inc: 6 sales, last Feb 6, 2023
  • SCPH scPharmaceuticals Inc: other filings, last Jan 17, 2018

Get free alerts when Abraham Ceesay files a new trade →